Medical News

RSS

Scammers look to take advantage of health law

The Green Bay CBS affiliate is reporting that the "Better Business Bureau is putting out an alert about health insurance related scams." Scammers have been more active since the health bill passed.

2 Jun 2010

Tomorrow's elderly will need to pay for care

As their autonomy fades, tomorrow's elderly will need to create non-traditional support networks or pay for the care they receive.

2 Jun 2010

McGill University granted 'Orphan Drug Designation' for pulmonary infection drug fenretinide

In addition to their suffering, rare disease patients often have to face the harsh reality that few pharmaceutical companies will ever be able to offer new treatments for their condition because the costs of new treatments will never be recovered from such a small market. But there are ways they can be helped. The U.S. Food and Drug Administration's "Orphan Drug Designation" offers a wide range of benefits that help organizations developing treatments for diseases and conditions affecting fewer than 200,000 patients in the United States.

2 Jun 2010

New report shows one in three young women receive HPV vaccine to prevent cervical cancer

Only about one in three young women has received the human papillomavirus vaccine to help prevent cervical cancer, according to a new report from researchers at Washington University School of Medicine in St. Louis.

2 Jun 2010

Cancer patients should find ways to be physically active during and after treatment: New national guidelines

Cancer patients who've been told to rest and avoid exercise can - and should - find ways to be physically active both during and after treatment, according to new national guidelines. Kathryn Schmitz, PhD, MPH, an associate professor of Epidemiology and Biostatistics and a member of the Abramson Cancer Center at the University of Pennsylvania School of Medicine, will present these guidelines at an educational session at the 2010 meeting of the American Society of Clinical Oncology, aimed at making cancer exercise rehabilitation programs as common as those offered to people who have had heart attacks or undergone cardiac surgery.

2 Jun 2010

Scientists discover key mechanism of cancer cells

Many tumor cells would not be viable due to aberrant chromosome distribution if they had not developed a special trick. Scientists from the German Cancer Research Center have investigated which genes are responsible for this survival strategy of cancer cells.

2 Jun 2010

Onyx Pharmaceuticals commences Phase 1 study of ONX 0912 oral proteasome inhibitor for cancer

Onyx Pharmaceuticals, Inc. today announced the initiation of a Phase 1 study of ONX 0912, an oral proteasome inhibitor, in patients with advanced refractory or recurrent solid tumors.

2 Jun 2010

Obama administration sides with city in San Francisco lawsuit

"The Obama administration took San Francisco's side Friday in a legal dispute over the city's groundbreaking health coverage law, urging the Supreme Court to reject an appeal by restaurant owners who objected to paying part of the cost. In a long-awaited filing, government lawyers said passage of national health insurance legislation 'has dramatically changed the landscape' and reduced the likelihood that cities and states would adopt laws like San Francisco's. The case presents no pressing issues that require the court's review, the lawyers said."

2 Jun 2010

Medicare patients may face accessibility crisis to medical care

According to an article in the June issue of the Journal of Bone and Joint Surgery (JBJS), Medicare patients - many who suffer from disabling arthritis of the hip and knee, among other age-related ailments - may end up facing an accessibility crisis to medical care.

2 Jun 2010

Infighting threatens COBRA subsidy extension, longer Medicare doc pay 'fix'

Roll Call reports that infighting over some unemployment benefits and a scheduled "fix" of Medicare physician payments has left Democratic congressional leaders at a "dramatic low" in their relationship. "And while publicly, House and Senate leaders refused to assign blame, the behind-the-scenes story was far different. The deadline for the benefits package had been looming for weeks.

2 Jun 2010

Study sheds light on molecular mechanisms of genital and urinary tract abnormalities

Scientists have learned how a gene widely known for precisely positioning and sculpting various organs also controls the speed of cell division, a finding that could be useful for understanding the explosive growth of cancer cells or why increasing numbers of children are being born with genital and urinary tract malformations.

2 Jun 2010

EMBL scientists identify two small RNA molecules that ensure red blood cell production

Red blood cells, the delivery men that take oxygen to cells all around the body, have short lives. To keep enough of them in circulation, the human body produces around 2 million of these cells every second - even more in response to challenges like severe blood loss. In a study published today in the Journal of Experimental Medicine, scientists at the European Molecular Biology Laboratory in Monterotondo, Italy, and EMBL's European Bioinformatics Institute in Hinxton, UK, have identified two small RNA molecules which ensure that enough red blood cells are produced efficiently, by fine-tuning a number of different genes involved in this process.

2 Jun 2010

Postdoctoral scientists receive NYSCF-Druckenmiller Fellowship award

The New York Stem Cell Foundation (NYSCF) today announced the award of eight new NYSCF-Druckenmiller Fellows. These postdoctoral scientists join 15 accomplished stem cell researchers from leading institutions who have been supported by the program since 2006. NYSCF has awarded 23 fellowships to date.

2 Jun 2010

Men with ED are at increased risk of high CACS: Researchers

In the largest study to date evaluating erectile dysfunction and coronary artery calcification, researchers at Mount Sinai School of Medicine have determined that men with ED are at a significantly increased risk of high coronary artery calcification scores, a known predictor of future cardiovascular events.

2 Jun 2010

FDA accepts Orexigen's Contrave NDA for treatment of obesity

Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company's New Drug Application (NDA) for Contrave® (naltrexone SR/bupropion SR), its investigational drug for the treatment of obesity.

2 Jun 2010

Over-the-counter supplements can cause hypertension and kidney failure

Negative health effects linked to taking too much supplemental calcium are on the rise, according to a commentary appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN).

2 Jun 2010

Canada willing to spend $1B on G8 maternal, child health initiative

Canada has told other G8 countries that it "is willing to put about $1 billion toward maternal and child health - as long as other countries ante up, too," the Canadian Press/Winnipeg Free Press reports.

2 Jun 2010

Health law implementation: Insurance, coverage and Medicare payment questions

Kaiser Health News reports that the insurance industry — traditionally a state-regulated industry — is facing new federal scrutiny by four officials in the new Office of Consumer Information and Insurance Oversight. "On this year's to-do list: writing rules to define when premium increases are 'unreasonable,' creating new coverage for people who can't get it because of health conditions and making sure insurers comply with consumer protections. The new director of the office is Jay Angoff, a former Missouri insurance commissioner.

2 Jun 2010

Amgen's Prolia receives FDA approval for treatment of postmenopausal women with osteoporosis

Amgen Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Prolia™ (denosumab) for the treatment of postmenopausal women with osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or patients who have failed or are intolerant to other available osteoporosis therapy. Prolia, the first and only FDA-approved RANK Ligand inhibitor, is an every six month 60 mg subcutaneous injection administered by a health care professional.

2 Jun 2010

Teva Pharmaceutical launches Gianvi Tablets

Teva Pharmaceutical Industries Ltd. announced today that it has commercially launched Gianvi (Drospirenone and Ethinyl Estradiol) Tablets, the Company's generic version of Bayer's Yaz® Tablets.

2 Jun 2010

Medical News

Scammers look to take advantage of health law

Tomorrow's elderly will need to pay for care

McGill University granted 'Orphan Drug Designation' for pulmonary infection drug fenretinide

New report shows one in three young women receive HPV vaccine to prevent cervical cancer

Cancer patients should find ways to be physically active during and after treatment: New national guidelines

Scientists discover key mechanism of cancer cells

Onyx Pharmaceuticals commences Phase 1 study of ONX 0912 oral proteasome inhibitor for cancer

Obama administration sides with city in San Francisco lawsuit

Medicare patients may face accessibility crisis to medical care

Infighting threatens COBRA subsidy extension, longer Medicare doc pay 'fix'

Study sheds light on molecular mechanisms of genital and urinary tract abnormalities

EMBL scientists identify two small RNA molecules that ensure red blood cell production

Postdoctoral scientists receive NYSCF-Druckenmiller Fellowship award

Men with ED are at increased risk of high CACS: Researchers

FDA accepts Orexigen's Contrave NDA for treatment of obesity

Over-the-counter supplements can cause hypertension and kidney failure

Canada willing to spend $1B on G8 maternal, child health initiative

Health law implementation: Insurance, coverage and Medicare payment questions

Amgen's Prolia receives FDA approval for treatment of postmenopausal women with osteoporosis

Teva Pharmaceutical launches Gianvi Tablets

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News